Epstein-Barr virus in hepatocellular carcinogenesis

World Journal of Gastroenterology

Volumn 10, Issue 23, 2004, Pages 3409-3413

  Li, Wei ^a   Wu, Bao An ^a   Zeng, Yong Ming ^a   Chen, Guang Can ^a   Li, Xin Xin ^a   Chen, Jun Tian ^a   Guo, Yu Wen ^a   Li, Man Hong ^a   Zeng, Yi ^b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBULIN; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; LATENT MEMBRANE PROTEIN 1; VIRUS DNA; VIRUS RNA;

ADULT; AGED; ARTICLE; CELL NUCLEUS; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DNA SEQUENCE; EPSTEIN BARR VIRUS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER RESECTION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MESENCHYME CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TUMOR CELL; VIRUS DETECTION; VIRUS INFECTION;

EID: 9244235481     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i23.3409     Document Type: Article

References (26)

1. Huang YP, Guo XC, He ZG, Zhao J, Zeng Y. Epstein-Barr virus induced thymus malignant T cell lymphoma. Bindu Xuebao 2001; 17: 289-294
2. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-1354
3. Bell A, Rickinson AB. Epstein-Barr virus, the TCL-1 oncogene and Burkitt's lymphoma. Trends Microbiol 2003; 11: 495-497
4. Yachie A, Kanegane H, Kasahara Y. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases. Semin Hematol 2003; 40: 124-132
5. Kuo T, Hsueh C. Lymphoepithelioma-like salivary gland carcinoma in Taiwan: a clinicopathological study of nine cases demonstrating a strong association with Epstein-Barr virus. Histopathology 1997; 31: 75-82
6. Mok MY, Shek WH, Wong RW. Lymphoepithelioma-like carcinoma of the parotid gland in a patient with rheumatoid arthritis. Clin Exp Rheumatol 2002; 20: 848-850
7. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004; 350: 1328-1337
8. Gandhi MK, Tellam JT, Khanna R. Epstein-Barr virus-associated Hodgkin's lymphoma. Br J Haematol 2004; 125: 267-281
9. Mladenova I, Pellicano R. Infectious agents and gastric tumours. An increasing role for Epstein-Barr virus. Panminerva Med 2003; 45: 183-188
10. Wakiguchi H. Overview of epstein-barr virus-associated diseases in Japan. Crit Rev Oncol Hematol 2002; 44: 193-202
11. Sugawara Y, Mizugaki Y, Uchida T, Torii T, Imai S, Makuuchi M, Takada K. Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology 1999; 256 196-202
12. Sugawara Y, Makuuchi M, Kato N, Shimotohno K, Takada K. Enhancement of hepatitis C virus replication by epstein-barr virus-encoded nuclear antigen 1. EMBO J 1999; 18: 5755-5760
13. Sugawara Y, Makuuchi M, Takada K. Detection of Epstein-Barr virus DNA in hepatocellular carcinoma tissues from hepatitis C-positive patients. Scand J Gastroenterol 2000; 35: 981-984
14. Cheng JL, Liu BL, Zhang Y, Tong WB, Yan Z, Feng BF. Hepatitis C virus in human B lymphocytes transformed by Epstein-Barr virus in vitro by in situ reverse transcriptase-polymerase chain reaction. World J Gastroenterol 2001; 7: 370-375
15. Chu PG, Chen YY, Chen W, Weiss LM. No direct role for Epstein-Barr virus in American hepatocellular carcinoma. Am J Pathol 2001; 159: 1287-1292
16. Akhter S, Liu H, Prabhu R, DeLucca C, Bastian F, Garry RF, Schwartz M, Thung SN, Dash S. Epstein-Barr virus and human hepatocellular carcinoma. Cancer Lett 2003; 192: 49-57
17. Junying J, Herrmann K, Davies G, Lissauer D, Bell A, Timms J, Reynolds GM, Hubscher SG, Young LS, Niedobitek G, Murray PG. Absence of Epstein-Barr virus DNA in the tumor cells of european hepatocellular carcinoma. Virology 2003; 306: 236-243
18. Zur Hausen A, van Beek J, Bloemena E, ten Kate FJ, Meijer CJ, van den Brule AJ. No role for Epstein-Barr virus in Dutch hepatocellular carcinoma: a study at the DNA, RNA and protein levels. J Gen Virol 2003; 84(Pt 7): 1863-1869
19. Herrmann K, Niedobitek G. Epstein-Barr virus-associated carcinomas: facts and fiction. J Pathol 2003; 199: 140-145
20. Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G, Joab I. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 1999; 91: 1376-1381
21. Chu PG, Chang KL, Chen YY, Chen WG, Weiss LM. No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am J Pathol 2001; 159: 571-578
22. Touitou R, Bonnet-Duquenoy M, Joab I. Association of Epstein-Barr virus with human mammary carcinoma. Pros and cons. Dis Markers 2001; 17: 163-165
23. Preciado MV. Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma-another point of view. Breast Cancer Res 2003; 5: E6
24. Wang LS, Chow KC, Wu YC, Li WY, Huang MH. Detection of Epstein-Barr virus in esophageal squamous cell carcinoma in Taiwan. Am J Gastroenterol 1999; 94: 2834-2839
25. Kijima Y, Hokita S, Takao S, Baba M, Natsugoe S, Yoshinaka H, Aridome K, Otsuji T, Itoh T, Tokunaga M, Eizuru Y, Aikou T. Epstein-Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma among various epithelial neoplasms. J Med Virol 2001; 64: 513-518
26. Yuan FP, Huang PS, Wang Y, Gong HS. Relationship between EBV infection in fujian HCC and HBV and P53 protein expression. Shijie Huaren Xiaohua Zazhi 1999; 7: 491-493